Upon recognition of T cell receptor (TCR) of tumor cells, of which tumor-specific antigen is presented by major histocompatibility complex class I (MHC-I), CD8 T cells can kill tumor cells through producing cytotoxic molecules, such as granzymes and perforin (15). This evidence concerns the gene PRF1 and neoplasm.